Results 41 to 50 of about 29,315 (207)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review

Pharmacy, 2016
The purpose of this article is to report a case of fondaparinux outpatient utilization for anticoagulation in a patient with a past medical history of heparin-induced thrombocytopenia (HIT) and discuss the options and need for future anticoagulation ...
Amy Christopher
doaj   +1 more source

Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study

Italian Journal of Medicine, 2013
The majority of acutely ill medical patients are elderly with some degree of renal impairment. In this setting, venous thromboembolism (VTE) is one of the leading causes of morbidity and mortality and, to reduce this risk, a correct thromboprophylaxis is
Federico Silvestri, Samantha Pasca, Marco Zaramella, Antonella Labombarda, Andrea Barbi, Mauro Desideri, Paolo Guidi, Adolfo Rogato, Matteo Bergamo, Giovanni Barillari   +9 more
doaj   +1 more source

The Fondaparinux Paradox: Fondaparinux-Related Heparin-Induced Thrombocytopenia

Indian Journal of Critical Care Medicine, 2018
Fondaparinux, a pentasaccharide administered for heparin-induced thrombocytopenia (HIT), can lead to the occurrence of thrombocytopenia. This patient underwent aortic stent graft placement for Salmonella paratyphi A-infected abdominal aortic aneurysm.
Vadi, Sonali, Peshattiwar, Vishal
openaire   +2 more sources

Fondaparinux versus Enoxaparina no Tratamento de Pacientes Obesos com Síndrome Coronariana Aguda [PDF]

Arquivos Brasileiros de Cardiologia
Resumo Fundamento: O fondaparinux é um anticoagulante eficaz e seguro usado no tratamento de síndromes coronarianas agudas (SCAs). No entanto, devido à baixa representatividade de indivíduos obesos em ensaios clínicos, os efeitos de se aplicar os ...
Beatriz Rocha Darzé, Carolina Costa da Silva Souza, Queila Borges de Oliveira, João Victor Santos Pereira Ramos, Mateus S. Viana, Eduardo Sahade Darzé, Luiz Eduardo Fonteles Ritt   +6 more
doaj   +1 more source

Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region.

PLoS ONE, 2023
IntroductionLow Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects.ObjectivesThe ...
Giaele Moretti, Bruna Vinci, Simona Zito, Alessia Caputo, Francesco Attanasio, Milena Vainieri   +5 more
doaj   +1 more source

Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia. [PDF]

, 2014
PURPOSE OF REVIEW: To review the recent developments in understanding the pathophysiology of heparin-induced thrombocytopenia (HIT) and in applying this knowledge to the treatment of patients with suspected and proven HIT.
McKenzie, Steven E., Sachais, Bruce S
core   +1 more source

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants [PDF]

, 2016
Cancer patients are at major risk of developing Venous Thromboembolism (VTE), resulting in increased morbidity and economic burden. While a number of theories try to explain its pathophysiology, its risk stratification can be broadly done in cancer ...
Fatima Khalid, Hina Farooq, mouaz al-mallah, Shayan Qadir, Waqas Qureshi, Waseem Amjad, Zaid Alirhayim, Zeeshan Ali, Zeeshan Ali   +8 more
core   +3 more sources

Pathogenic PF4/Polyanion ELISA‐Negative Antibodies in HIT

American Journal of Hematology, EarlyView.
ABSTRACT Background Platelet factor 4‐polyanion enzyme‐linked immunosorbent assays (ELISAs) are considered highly sensitive for diagnosing heparin‐induced thrombocytopenia (HIT), such that current practice guidelines recommend use of ELISA‐negative results to exclude HIT.
Adam J. Kanack, Noah P. Splinter, Emily E. Mauch, Leben Tefera, Morayma Reyes Gil, Sakshi Jasra, Andrew Goodwin, Kristi J. Smock, Hadiyah Ahmad, Aneel Ashrani, Nathaniel L. Robinson, Ana I. Casanegra, Curtis G. Jones, Shannon M. Pechauer, Erin Yttre, Richard H. Aster, Mindy C. Kohlhagen, Rachel R. Leger, Gretchen Johns, David L. Murray, Lu Zhou, Demin Wang, Renren Wen, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan   +25 more
wiley   +1 more source

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol

BMC Pharmacology and Toxicology, 2023
Plain Language Summary New Fondaparinux Protocol to Reduce the Risk of Blood Thickening and Blood Clots Formation in Adults with Kidney Disease and Heparin-induced Thrombocytopenia (drop in platelets after the use of heparin): A Test Study.
Dania Ghaziri, Hassan Dehaini, Mayyas Msheik, Marwan Bahmad, Maya Zorkot, George Abi Saad   +5 more
doaj   +1 more source

Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline [PDF]

, 2018
Lumbar puncture (LP) is an important and frequently performed invasive procedure for the diagnosis and management of neurological conditions. There is little in the neurological literature on the topic of periprocedural management of antithrombotics in ...
Chhetri, Suresh, Desborough, Michael J R, Dodd, Katherine Claire, Emsley, Hedley C A   +3 more
core   +1 more source